These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21546834)

  • 41. HIV in the tropics: staging in the resource-limited setting.
    Varughese JK; Rosenberg MG; Kim K
    Curr Opin Infect Dis; 2012 Oct; 25(5):477-83. PubMed ID: 22744319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.
    Boyer S; Koulla-Shiro S; Abé C; Spire B; Moatti JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):239-44. PubMed ID: 21537170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.
    Wright ST; Carr A; Woolley I; Giles M; Hoy J; Cooper DA; Law MG;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):72-9. PubMed ID: 21654498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
    Braitstein P; Brinkhof MW; Dabis F; Schechter M; Boulle A; Miotti P; Wood R; Laurent C; Sprinz E; Seyler C; Bangsberg DR; Balestre E; Sterne JA; May M; Egger M; ;
    Lancet; 2006 Mar; 367(9513):817-24. PubMed ID: 16530575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. When to start antiretroviral therapy in adults in low- and middle-income countries: science and practice.
    Munderi P
    Curr Opin HIV AIDS; 2010 Jan; 5(1):6-11. PubMed ID: 20046142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Socio-economic determinants of disease progression among HIV infected adults in Kenya.
    Gitahi-Kamau NT; Kiarie JN; Mutai KK; Gatumia BW; Gatongi PM; Lakati A
    BMC Public Health; 2015 Jul; 15():733. PubMed ID: 26227658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for Action on HIV Treatment and Care Systems in low and middle-income countries: background and introduction.
    Ross DA; South A; Weller I; Hakim J
    AIDS; 2012 Dec; 26 Suppl 2():S93-5. PubMed ID: 23303437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive impairment and neuroCART.
    Wright E
    Curr Opin HIV AIDS; 2011 Jul; 6(4):303-8. PubMed ID: 21546833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.
    Wright ST; Petoumenos K; Boyd M; Carr A; Downing S; O'Connor CC; Grotowski M; Law MG;
    HIV Med; 2013 Apr; 14(4):208-16. PubMed ID: 23036045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid CD4+ cell decrease after transient cART initiated during primary HIV infection (ANRS PRIMO and SEROCO cohorts).
    Seng R; Goujard C; Desquilbet L; Sinet M; Rouzioux C; Deveau C; Boufassa F; Delfraissy JF; Meyer L; Venet A;
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):251-8. PubMed ID: 18845951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.
    Bartlett JA; Shao JF
    Lancet Infect Dis; 2009 Oct; 9(10):637-49. PubMed ID: 19778766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    Teeraananchai S; Kerr SJ; Amin J; Ruxrungtham K; Law MG
    HIV Med; 2017 Apr; 18(4):256-266. PubMed ID: 27578404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.
    Koller M; Patel K; Chi BH; Wools-Kaloustian K; Dicko F; Chokephaibulkit K; Chimbetete C; Avila D; Hazra R; Ayaya S; Leroy V; Truong HK; Egger M; Davies MA;
    J Acquir Immune Defic Syndr; 2015 Jan; 68(1):62-72. PubMed ID: 25501345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.
    García M; Jiménez-Sousa MA; Blanco J; Restrepo C; Pacheco YM; Brochado-Kith Ó; López-Bernaldo JC; Gutiérrez F; Portilla J; Estrada V; Górgolas M; Cabello A; Resino S; Benito JM; Rallón N;
    Antiviral Res; 2019 Oct; 170():104577. PubMed ID: 31386862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern, Determinants, and Impact of HIV Spending on Care and Treatment in 38 High-Burden Low- and Middle-Income Countries.
    Granich R; Gupta S; Montaner J; Williams B; Zuniga JM
    J Int Assoc Provid AIDS Care; 2016; 15(2):91-100. PubMed ID: 26715490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.
    Dabis F; Balestre E; Braitstein P; Miotti P; Brinkhof WG; Schneider M; Schechter M; Laurent C; Boulle A; Kabugo C; Capkun G; Seyler C; McIntyre J; Sprinz E; Bangsberg D; Van der Borght S; Egger M;
    Int J Epidemiol; 2005 Oct; 34(5):979-86. PubMed ID: 16157617
    [No Abstract]   [Full Text] [Related]  

  • 58. Monitoring HIV treatment in the developing world.
    Kumarasamy N; Flanigan TP; Mahajan AP; Carpenter CC; Mayer KH; Solomon S
    Lancet Infect Dis; 2002 Nov; 2(11):656-7. PubMed ID: 12409043
    [No Abstract]   [Full Text] [Related]  

  • 59. Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.
    Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA
    AIDS; 2013 May; 27(8):1245-51. PubMed ID: 23276809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.
    ; ; Brinkhof MW; Egger M; Boulle A; May M; Hosseinipour M; Sprinz E; Braitstein P; Dabis F; Reiss P; Bangsberg DR; Rickenbach M; Miro JM; Myer L; Mocroft A; Nash D; Keiser O; Pascoe M; van der Borght S; Schechter M
    Clin Infect Dis; 2007 Dec; 45(11):1518-21. PubMed ID: 17990236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.